Ragni M V, Lewis J H, Spero J A, Hasiba U
Alcohol Clin Exp Res. 1982 Spring;6(2):267-74. doi: 10.1111/j.1530-0277.1982.tb04973.x.
Coagulation profiles were performed in 30 consecutive alcoholic cirrhotic patients without known infection, malignancy, recent surgery, transfusion, or alcoholic intake. Hemorrhagic phenomena were present in 70% and included gastrointestinal bleeding, oozing from venipuncture sites, bruising, and epistaxis. All 30 patients had multiple liver function and coagulation abnormalities, the most frequent of which were increases in F VIII components and decreases in F XI and F VII. Also decreased in half or more of the 30 patients were Fletcher F, F II, F X, prothrombin time (PT), partial thromboplastin time (APTT), thrombin time (TT), reptilase time (RT), anti-thrombin III, and plasminogen. When comparing cirrhotic bleeders with nonbleeders, four parameters were significantly different in those with a bleeding tendency: F VII, anti-thrombin III, plasminogen, and albumin. The prolonged APTT was associated in four cases with a blocking inhibitor of unknown etiology. The prolonged TT and RT, in the absence of fibrin split products, fibrin monomers, DIC, or shortened euglobulin lysis time in any patient were suggestive of an abnormal fibrinogen, a dysfibrinogen. In three other patients, there was an inhibitor of the TT. Further investigation of the suspected dysfibrinogen in 21 patients by SDS-polyacrylamide gel electrophoresis revealed that the molecular weights of the Aalpha, Bbeta, and gamma polypeptide chains of fibrinogen were not different from normal. Two-dimensional immunoelectrophoresis of the suspected dysfibrinogen was similar to normal in 18 of 21 patients, with loss of the initial shoulder in three.
对30例连续的酒精性肝硬化患者进行了凝血指标检测,这些患者无已知感染、恶性肿瘤、近期手术、输血或酒精摄入史。70%的患者出现出血现象,包括胃肠道出血、静脉穿刺部位渗血、瘀斑和鼻出血。所有30例患者均有多种肝功能和凝血异常,最常见的是F VIII成分增加以及F XI和F VII降低。30例患者中半数或更多患者的Fletcher F、F II、F X、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、爬虫酶时间(RT)、抗凝血酶III和纤溶酶原也降低。将肝硬化出血患者与非出血患者进行比较时,有出血倾向的患者在四个参数上有显著差异:F VII、抗凝血酶III、纤溶酶原和白蛋白。4例患者的APTT延长与病因不明的阻断性抑制剂有关。在任何患者中,TT和RT延长,且不存在纤维蛋白降解产物、纤维蛋白单体、弥散性血管内凝血(DIC)或优球蛋白溶解时间缩短,提示纤维蛋白原异常,即异常纤维蛋白原血症。另外3例患者存在TT抑制剂。通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳对21例疑似异常纤维蛋白原血症患者进行进一步研究,结果显示纤维蛋白原的Aα、Bβ和γ多肽链分子量与正常无异。21例患者中有18例疑似异常纤维蛋白原血症的二维免疫电泳结果与正常相似,3例患者的初始峰消失。